scispace - formally typeset
N

Nai Wen Chang

Researcher at China Medical University (Taiwan)

Publications -  14
Citations -  469

Nai Wen Chang is an academic researcher from China Medical University (Taiwan). The author has contributed to research in topics: Cancer & Fenofibrate. The author has an hindex of 10, co-authored 14 publications receiving 405 citations.

Papers
More filters
Journal ArticleDOI

Co-treating with arecoline and 4-nitroquinoline 1-oxide to establish a mouse model mimicking oral tumorigenesis.

TL;DR: Data subsequently attained from this mouse model support a role for alphaB-crystallin and Hsp27 as clinical markers for tumor progression and the study of the promoting effects of arecoline on tongue tumorigenesis.
Journal Article

Association of XRCC4 codon 247 polymorphism with oral cancer susceptibility in Taiwan.

TL;DR: The results provide the first evidence that the heterozygous A allele of the XRCC4 codon 247 may be associated with the development of oral cancer and may be a novel useful marker for primary prevention and anticancer intervention.
Journal ArticleDOI

AMPK-dependent signaling modulates the suppression of invasion and migration by fenofibrate in CAL 27 oral cancer cells through NF-κB pathway

TL;DR: Fenofibrate considerably inhibited metastatic behaviors of CAL 27 cells might be mediated through blocking NF‐κB signaling, resulting in the inhibition of MMPs; these effects were AMPK‐dependent rather than PPARα signaling.
Journal ArticleDOI

Fenofibrate Suppresses Oral Tumorigenesis via Reprogramming Metabolic Processes: Potential Drug Repurposing for Oral Cancer.

TL;DR: The present study demonstrates that fenofibrate provided novel mechanisms for delaying oral tumor development via the reprogramming of metabolic processes, and provides a molecular rationale whereby fen ofibrate exerts anticancer and additional beneficial effects for the treatment of oral cancer patients.